Evidence map›Paper›PMID 34289986›Full record

ArticleCancer research2021

Hedgehog Signaling Regulates Metabolism and Polarization of Mammary Tumor-Associated Macrophages.

Dominique C Hinshaw, Ann Hanna, Tshering Lama-Sherpa, Brandon Metge, Sarah C Kammerud, Gloria A Benavides, Atul Kumar, Heba Allah Alsheikh, Mateus Mota, Dongquan Chen and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 124 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Dominique C HinshawDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.
Ann HannaVanderbilt Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, Tennessee.
Tshering Lama-SherpaDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0003-2057-1962
Brandon MetgeDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.
Sarah C KammerudDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0002-4808-1618
Gloria A BenavidesDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.
Atul KumarDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0001-9578-2823
Heba Allah AlsheikhDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0002-7006-5294
Mateus MotaDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.
Dongquan ChenDivision of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0002-5006-5342
Scott W BallingerDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.
Jeffrey C RathmellVanderbilt Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, Tennessee.
Selvarangan PonnazhaganDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.
Victor Darley-UsmarDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.
Rajeev S SamantDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0001-5681-4976
Lalita A ShevdeDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama. lsamant@uab.edu.
University of Alabama at Birmingham · USVanderbilt University · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
Dietary intervention of non-classical Wnt signalingR01CA194048 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAMANT, RAJEEV S · 2016 to 2020
$1.7M
Mechanisms of resistance to cancer therapeuticsR01CA169202 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SHEVDE, LALITA A. · 2014 to 2018
$1.5M
NCI NIH HHS P30 CA013148NCI NIH HHS R01 CA169202NCI NIH HHS R01 CA194048NIAMS NIH HHS P30 AR048311
6 · The paper itself

Abstract

Elevated infiltration of immunosuppressive alternatively polarized (M2) macrophages is associated with poor prognosis in patients with cancer. The tumor microenvironment remarkably orchestrates molecular mechanisms that program these macrophages. Here we identify a novel role for oncogenic Hedgehog (Hh) signaling in programming signature metabolic circuitries that regulate alternative polarization of tumor-associated macrophages. Two immunocompetent orthotopic mouse models of mammary tumors were used to test the effect of inhibiting Hh signaling on tumor-associated macrophages. Treatment with the pharmacologic Hh inhibitor vismodegib induced a significant shift in the profile of tumor-infiltrating macrophages. Mass spectrometry-based metabolomic analysis showed Hh inhibition induced significant alterations in metabolic processes, including metabolic sensing, mitochondrial adaptations, and lipid metabolism. In particular, inhibition of Hh in M2 macrophages reduced flux through the UDP-GlcNAc biosynthesis pathway. Consequently, O-GlcNAc-modification of STAT6 decreased, mitigating the immune-suppressive program of M2 macrophages, and the metabolically demanding M2 macrophages shifted their metabolism and bioenergetics from fatty acid oxidation to glycolysis. M2 macrophages enriched from vismodegib-treated mammary tumors showed characteristically decreased O-GlcNAcylation and altered mitochondrial dynamics. These Hh-inhibited macrophages are reminiscent of inflammatory (M1) macrophages, phenotypically characterized by fragmented mitochondria. This is the first report highlighting the relevance of Hh signaling in controlling a complex metabolic network in immune cells. These data describe a novel immunometabolic function of Hh signaling that can be clinically exploited. SIGNIFICANCE: These findings illustrate that Hh activity regulates a metabolic and bioenergetic regulatory program in tumor-associated macrophages that promotes their immune-suppressive polarization.

Indexed as

MetabolomeTumor MicroenvironmentAnimalsApoptosisBiomarkers, TumorBreast NeoplasmsCell ProliferationEnergy MetabolismFemaleGlycolysisHedgehog ProteinsHumansLipid MetabolismMiceMice, Inbred BALB CMice, NudeBiomarkers, TumorHedgehog Proteins

Identifiers

PMID34289986
PMCPMC8563376
OpenAlexW3184643124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.